Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Advanced Proteome Therapeutics Corporation V.APC.H

Alternate Symbol(s):  APTCF

Healthcare Biotechnology
Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.


TSXV:APC.H - Post by User

Advanced Proteome Therapeutics Corporation
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(27)
•••
Post by Goldnboy1on Aug 02, 2022 6:10pm
218 Views
Post# 34866852

Comparables

Comparables

At this stage comparable companies typically trade for $50M as a base and many are near or over $100M.

Two or Three more patents expected right around the corner! 

Have to think as those patents are issued and toxin collaborators begin to partner up, that this stock will have a lot of reason for new buying activity going forward!!!

Great day shareholders. Keep up the good work! Let's finish the week in the $0.30-$0.50 range!!

Any real volume and this is going to keep re-rating itself fast!!

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities